Tirzepatide, a groundbreaking FDA-approved weight loss medication, could be the solution you're seeking
[PubMed] Jastreboff AM, Aronne LJ, Ahmad NN, et al
Weight Loss Results: Head-to-Head Data Semaglutide Clinical Trial Results The STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the most comprehensive dataset for any anti-obesity medication: STEP 1 (Wilding et al., 2021, NEJM ): 1,961 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Semaglutide 2.4 mg weekly vs
Temperature fluctuations: Even brief excursions to elevated temperature during transit or handling can accelerate degradation
Some individuals on Zepbound have reported unpredictable cycles, irregular bleeding, and changes to their flow